Trial NCT02899026

View at ClinicalTrials.gov 
Org. Study IDs: 205012

Last trial update was posted on 2017-11-20

MeSH Interventions

Antibodies, Monoclonal Prednisone

MeSH Conditions

Giant Cell Arteritis Polymyalgia Rheumatica

Other Conditions


Stopping Reasons

GSK decision to return rights to sirukumab to Janssen and discontinue sirukumab development in polymyalgia rheumatica.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID